JODY KAPUSTKA: Open Payments
NPI 1275834012 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 13 payments from 8 companies in 2025. Trend: 2023 $1,492 · 2024 $550 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $162 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| Lundbeck LLC | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Tris Pharma Inc | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Corium, LLC | 1 | $7 |
Products named: SPRAVATO, REXULTI, FANAPT, TRINTELLIX, Dyanavel XR, VRAYLAR, Azstarys.
Industry payments across IA — which companies pay providers there.
